Search for: "Amylin Pharmaceuticals, Inc."
Results 1 - 20
of 51
Sorted by Relevance
|
Sort by Date
3 Jul 2013, 12:27 pm
Amylin Pharmaceuticals Inc. et al Court Case Number: 1:13-cv-01061-TWP-DMLFile Date: Tuesday, July 02, 2013Plaintiff: Consumer Health Information CorporationPlaintiff Counsel: James Dimos of Frost Brown Todd LLCDefendant: Amylin Pharmaceuticals Inc. [read post]
12 May 2009, 3:43 pm
In 2007 Amylin Pharmaceuticals issued 3.00% convertible senior notes due 2014. [read post]
2 Nov 2009, 11:04 pm
Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine's use by patients with severe kidney disease. [read post]
18 Apr 2012, 1:32 pm
Amylin Pharmaceuticals Inc., C.A. 7404-VCN (April 18, 2012) An advance notice bylaw requires stockholders to tell their company substantially in advance of a stockholders' meeting if they want to nominate someone to to be elected as a director at that upcoming meeting. [read post]
15 Aug 2013, 8:41 am
("CHIC") of Virginia sued Amylin Pharmaceuticals, Inc. and Amylin Pharmaceuticals, LLC (collectively, "Amylin"), both of Los Angeles, California and Eli Lilly & Co. [read post]
9 Jun 2011, 12:43 pm
Washington-based partners Thomas Barnett and Michael Imbroscio persuaded a San Diego federal judge to vacate a temporary restraining order granted to Amylin Pharmaceuticals Inc. and deny Amylin's motion for a preliminary injunction. [read post]
1 Sep 2008, 7:07 pm
The deaths were announced by Eli Lilly & Co. and Amylin Pharmaceuticals Inc. the companies manufacturing the drug. [read post]
12 May 2009, 9:32 am
Amylin Pharmaceuticals Inc., C.A. 4446-VCL (May 12, 2009) One defense against a hostile takeover is a provision that permits only "continuing directors" to approve certain important corporate acts. [read post]
21 Aug 2008, 5:03 pm
In an announcement Monday, the FDA warned patients taking Byetta, marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co., to discontinue use if they develop symptoms of the disorder and said doctors should consider other prescription options for patients with a history of pancreas problems. [read post]
27 Aug 2008, 3:43 pm
Eli Lilly and Amylin Pharmaceuticals Inc. reported yesterday after the close of business that there were reports of four new deaths in patients taking Byetta. [read post]
25 Sep 2009, 2:09 pm
.'s diabetes treatment Januvia/Sitagliptin and occurrences of acute pancreatitis, the same issue that sunk sales of Amylin Pharmaceuticals Inc.'s Byetta.From the FDA site:FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. [read post]
5 Nov 2009, 7:20 pm
The FDA reported Byetta (exenatide), a drug manufactured by Amylin Pharmaceuticals, Inc. and Eli Lilly and Company, prescribed to treat type 2 diabetes may pose serious kidney problems to patients. [read post]
18 Aug 2008, 8:13 pm
Byetta, an injectable drug used to treat adults with type 2 diabetes, is made by San Diego-based Amylin Pharmaceuticals, Inc. [read post]
18 Aug 2008, 8:13 pm
Byetta, an injectable drug used to treat adults with type 2 diabetes, is made by San Diego-based Amylin Pharmaceuticals, Inc. [read post]
12 May 2009, 4:21 pm
Amylin Pharmaceuticals, Inc., No. 4446-VCL (Del.Ch., May 12, 2009), read opinion here. [read post]
16 Mar 2009, 11:20 am
The report points out that this new analysis was funded by Amylin Pharmaceuticals Inc., the drug company that makes Byetta, and Eli Lilly & Co., which is Amylin's marketing partner for Byetta sales in the U.S. [read post]
4 Nov 2009, 2:03 am
Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. [read post]
4 Nov 2009, 2:03 am
Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. [read post]
24 Apr 2012, 1:06 pm
Amylin Pharmaceuticals, Inc., C.A. [read post]
2 Nov 2008, 3:38 pm
FDA is working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis. [read post]
